Antti Tanskanen

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: ACTA PSYCHIATRICA SCANDINAVICA. 2025;152(2):104-111
The Role of Antipsychotics and Mood Stabilizers in Preventing Sickness Absence Among Employed Individuals With Bipolar Disorder: A Nationwide Register-Based Study
Holm M; Tanskanen A; Tiihonen J; Taipale H
Article: BIPOLAR DISORDERS. 2025;27(3):192-204
Treatment Patterns for Incident Bipolar Disorder Among Nonrefugee Immigrants, Refugees, Second-Generation Immigrants, and Host Population in Sweden
Kautzky A; Pettersson E; Amin R; Akhtar A; Tanskanen A; Taipale H; Wancata J; Gemes K; Mittendorfer-Rutz E
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2025;151(4):537-547
Initiation of Antipsychotics During the First Year After First-Episode Psychosis: A Population-Based Study
Odsbu I; Hamina A; Hjellvik V; Handal M; Haram M; Tesli M; Tanskanen A; Taipale H
Article: AMERICAN JOURNAL OF PSYCHIATRY. 2025;182(4):341-348
Continuous Dopamine D2 Receptor Blockade and Long-Term Outcome in First-Episode Schizophrenia
Tiihonen J; Tanskanen A; Solmi M; Rubio JM; Correll CU; Kane JM; Taipale H
Article: ECLINICALMEDICINE. 2025;81:103108
Machine learning-based mortality risk assessment in first-episode bipolar disorder: a transdiagnostic external validation study
Lieslehto J; Tiihonen J; Lahteenvuo M; Kautzky A; Akhtar A; Armannsdottir B; Leucht S; Correll CU; Mittendorfer-Rutz E; Tanskanen A; Taipale H
Article: LANCET PSYCHIATRY. 2025;12(3):198-207
Real-world effectiveness of pharmacological maintenance treatment of bipolar depression: a within-subject analysis in a Swedish nationwide cohort
Ermis C; Taipale H; Tanskanen A; Vieta E; Correll CU; Mittendorfer-Rutz E; Tiihonen J
Article: LANCET PSYCHIATRY. 2025;12(2):122-130
Comparative effectiveness of antipsychotic treatment strategies for relapse prevention in first-episode schizophrenia in Finland: a population-based cohort study.
Taipale H; Tanskanen A; Howes O; Correll CU; Kane JM; Tiihonen J
Article: JOURNAL OF AFFECTIVE DISORDERS. 2025;368:136-142
Cause-specific mortality in treatment-resistant major depression: Population-based cohort study
Gustafsson TT; Taipale H; Lahteenvuo M; Tanskanen A; Svirskis T; Huoponen S; Tiihonen J
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2025;151(1):81-91
Dosing levels of antipsychotics and mood stabilizers in bipolar disorder: A Nationwide cohort study on relapse risk and treatment safety
Lintunen J; Hamina A; Lahteenvuo M; Paljarvi T; Tanskanen A; Tiihonen J; Taipale H
Article: JAMA PSYCHIATRY. 2025;82(1):94-98
Repurposing Semaglutide and Liraglutide for Alcohol Use Disorder
Lahteenvuo M; Tiihonen J; Solismaa A; Tanskanen A; Mittendorfer-Rutz E; Taipale H
Article: SCHIZOPHRENIA BULLETIN. 2024;50(6):1287-1294
Antipsychotic Use and Psychiatric Hospitalization in First-Episode Non-affective Psychosis and Cannabis Use Disorder: A Swedish Nationwide Cohort Study
Denissoff A; Taipale H; Tiihonen J; Di Forti M; Mittendorfer-Rutz E; Tanskanen A; Mustonen A; Niemela S
Article: SCHIZOPHRENIA BULLETIN. 2024;50(6):1471-1481
Antipsychotic Use and Risk of Breast Cancer in Women With Severe Mental Illness: Replication of a Nationwide Nested Case-Control Database Study
Solmi M; Laehteenvuo M; Tanskanen A; Corbeil O; Mittendorfer-Rutz E; Correll CU; Tiihonen J; Taipale H
Article: JAMA PSYCHIATRY. 2024;81(10):967-975
Pneumonia Risk, Antipsychotic Dosing, and Anticholinergic Burden in Schizophrenia
Luykx JJ; Correll CU; Manu P; Tanskanen A; Hasan A; Tiihonen J; Taipale H
Article: AMERICAN JOURNAL OF PSYCHIATRY. 2024;181(10):879-892
High Burden of Ileus and Pneumonia in Clozapine-Treated Individuals With Schizophrenia: A Finnish 25-Year Follow-Up Register Study
Partanen JJ; Happola P; Kampe A; Ahola-Olli A; Hellsten A; Rask SM; Haaki W; Hietala J; Kampman O; Tiihonen J; Tanskanen AJ; Daly MJ; Ripatti S; Palotie A; Taipale H; Lahteenvuo M; Koskela JT
Article: AMERICAN JOURNAL OF PSYCHIATRY. 2024;181(10):893-900
Real-World Effectiveness of Menopausal Hormone Therapy in Preventing Relapse in Women With Schizophrenia or Schizoaffective Disorder
Brand BA; Sommer IE; Gangadin SS; Tanskanen A; Tiihonen J; Taipale H
Article: JAMA NETWORK OPEN. 2024;7(10):e2438358
Comparative Effectiveness of Antipsychotics in Patients With Schizophrenia Spectrum Disorder
Hamina A; Taipale H; Lieslehto J; Laehteenvuo M; Tanskanen A; Mittendorfer-Rutz E; Tiihonen J
Article: BJPSYCH OPEN. 2024;10(5):e158
Characteristics of high-dose benzodiazepine use: nationwide cohort study on new benzodiazepine users with 5-year follow-up
Sarkila H; Taipale H; Tanskanen A; Kurko T; Taiminen T; Tiihonen J; Sund R; Saastamoinen L; Hietala J; Niemela S
Article: BMC PSYCHIATRY. 2024;24(1):623
Trajectories of work disability among individuals with anxiety-, mood/affective-, or stress-related disorders in a primary healthcare setting
Helgesson M; Pettersson E; Lindsater E; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Cullen AE
Article: PSYCHIATRY RESEARCH. 2024;339:116012
Dopamine D2 receptor antagonism of antipsychotics and the risk of death due to choking
Luykx JJ; Tanskanen A; Lahteenvuo M; Manu P; Correll CU; Hasan A; Lieslehto J; Taipale H; Tiihonen J
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2024;150(2):56-64
Cardiovascular mortality in bipolar disorder: Population-based cohort study
Paljarvi T; Herttua K; Taipale H; Lahteenvuo M; Tanskanen A; Tiihonen J
Article: WORLD PSYCHIATRY. 2024;23(2):276-284
Real-world effectiveness of antidepressants, antipsychotics and their combinations in the maintenance treatment of psychotic depression. Evidence from within-subject analyses of two nationwide cohorts
Taipale H; Lieslehto J; Laehteenvuo M; Hamina A; Tanskanen A; Mittendorfer-Rutz E; Paljaervi T; Solmi M; Cipriani A; Correll CU; Tiihonen J
Article: LANCET PSYCHIATRY. 2024;11(6):443-450
Long-term persistence of the risk of agranulocytosis with clozapine compared with other antipsychotics: a nationwide cohort and case-control study in Finland
Rubio JM; Kane JM; Tanskanen A; Tiihonen J; Taipale H
Article: SCHIZOPHRENIA RESEARCH. 2024;267:230-238
Antipsychotic medications and sleep problems in patients with schizophrenia
Cederlof E; Holm M; Taipale H; Tiihonen J; Tanskanen A; Lahteenvuo M; Lahdensuo K; Kampman O; Wegelius A; Isometsa E; Kieseppa T; Palotie A; Suvisaari J; Paunio T
Article: EUROPEAN PSYCHIATRY. 2024;67(1):e34
Long-term benzodiazepine use and risk of labor market marginalization in Finland: A cohort study with 5-year follow-up
Taipale H; Tanskanen A; Kurko T; Taiminen T; Sarkila H; Tiihonen J; Sund R; Niemela S; Saastamoinen L; Hietala J
Article: JAMA NETWORK OPEN. 2024;7(3):e240640
Development and Validation of a Machine Learning-Based Model of Mortality Risk in First-Episode Psychosis
Lieslehto J; Tiihonen J; Laehteenvuo M; Leucht S; Correll CU; Mittendorfer-Rutz E; Tanskanen A; Taipale H
Article: JAMA NETWORK OPEN. 2024;7(3):e242859
Attention-Deficit/Hyperactivity Disorder Medications and Work Disability and Mental Health Outcomes
Taipale H; Bergstrom J; Gemes K; Tanskanen A; Ekselius L; Mittendorfer-Rutz E; Helgesson M
Article: LANCET PSYCHIATRY. 2024;11(2):102-111
Efficacy and effectiveness of antipsychotics in schizophrenia: network meta-analyses combining evidence from randomised controlled trials and real-world data
Efthimiou O; Taipale H; Radua J; Schneider-Thoma J; Pinzon-Espinosa J; Ortuno M; Vinkers CH; Mittendorfer-Rutz E; Cardoner N; Tanskanen A; Fusar-Poli P; Cipriani A; Vieta E; Leucht S; Tiihonen J; Luykx JJ
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2024;149(1):41-51
Effect of severity of depression on augmentation of antidepressant medication in young adults with depression
Lampela P; Tanskanen A; Lahteenvuo M; Tiihonen J; Taipale H
Article: PSYCHOLOGICAL MEDICINE. 2024;54(1):148-158
Labour market integration among young adults diagnosed with attention-deficit/hyperactivity disorder (ADHD) at working age
Chen L; Mittendorfer-Rutz E; Bjorkenstam E; Rahman S; Gustafsson K; Kjeldgard L; Ekselius L; Taipale H; Tanskanen A; Helgesson M
Article: SCANDINAVIAN JOURNAL OF PUBLIC HEALTH. 2023;51(8):1222-1230
Use of benzodiazepine and related drugs in migrants and Finnish-born persons: a nationwide register-based study
Lehti V; Salama E; Niemela S; Tanskanen A; Gissler M; Suvisaari J; Taipale H
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2023;148(5):416-425
Use of antipsychotics and antidepressants in first-episode psychotic depression: A nationwide register-based study
Hamina A; Paljarvi T; Tanskanen A; Lahteenvuo M; Tiihonen J; Taipale H
Article: JOURNAL OF AFFECTIVE DISORDERS. 2023;340:237-244
Real-world use of pharmacological treatments for incident bipolar disorder: A Finnish nationwide cohort study
Koistinaho A; Poranen J; Tanskanen A; Tiihonen J; Taipale H; Lahteenvuo M
Article: BRITISH JOURNAL OF PSYCHIATRY. 2023;223(4):456-464
Real-world effectiveness of pharmacological treatments for bipolar disorder: register-based national cohort study
Lahteenvuo M; Paljarvi T; Tanskanen A; Taipale H; Tiihonen J
Article: SSM-POPULATION HEALTH. 2023;23:101444
Sustainable labour market participation among working young adults with diagnosed attention deficit/hyperactivity disorder (ADHD)
Helgesson M; Kjeldgard L; Bjorkenstam E; Rahman S; Gustafsson K; Taipale H; Tanskanen A; Ekselius L; Mittendorfer-Rutz E
Article: JOURNAL OF AFFECTIVE DISORDERS. 2023;333:403-408
Non-adherence to mood stabilizers and antipsychotics among persons with bipolar disorder-A nationwide cohort study
Lintunen J; Lahteenvuo M; Tanskanen A; Tiihonen J; Taipale H
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2023;147(6):603-613
Association of pharmacological treatments and real-world outcomes in borderline personality disorder
Lieslehto J; Tiihonen J; Lahteenvuo M; Mittendorfer-Rutz E; Tanskanen A; Taipale H
Article: JAMA NETWORK OPEN. 2023;6(6):e2317130
Comparative Effectiveness of Pharmacotherapies for the Risk of Attempted or Completed Suicide Among Persons With Borderline Personality Disorder
Lieslehto J; Tiihonen J; Lahteenvuo M; Mittendorfer-Rutz E; Tanskanen A; Taipale H
Article: SCHIZOPHRENIA. 2023;9(1):34
Real-world effectiveness of antidepressant use in persons with schizophrenia: within-individual study of 61,889 subjects
Puranen A; Koponen M; Laehteenvuo M; Tanskanen A; Tiihonen J; Taipale H
Article: AMERICAN JOURNAL OF PSYCHIATRY. 2023;180(5):377-385
Safety of Antipsychotic Polypharmacy Versus Monotherapy in a Nationwide Cohort of 61,889 Patients With Schizophrenia
Taipale H; Tanskanen A; Tiihonen J
Article: BMJ MENTAL HEALTH. 2023;26(1):e300700
Cause-specific excess mortality after first diagnosis of bipolar disorder: population-based cohort study
Paljarvi T; Herttua K; Taipale H; Lahteenvuo M; Tanskanen A; Fazel S; Tiihonen J
Article: FRONTIERS IN PSYCHIATRY. 2023;14:1152286
The role of sociodemographic and clinical factors in the initiation and discontinuation of attention deficit hyperactivity disorder medication among young adults in Sweden
Gemes K; Taipale H; Bjorkenstam E; Rahman S; Gustafsson K; Tanskanen A; Ekselius L; Mittendorfer-Rutz E; Helgesson M
Article: BJPSYCH OPEN. 2023;9(3):e57
Antipsychotic treatment patterns in refugees and their Swedish-born peers with first-episode non-affective psychosis: findings from the REMAIN study
Goppers JS; Mittendorfer-Rutz E; Cullen AE; de Montgomery CJ; Tanskanen A; Norredam M; Taipale H
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2023;147(3):257-266
Real-world effectiveness of mood stabilizer use in schizophrenia
Puranen A; Koponen M; Lahteenvuo M; Tanskanen A; Tiihonen J; Taipale H
Article: PSYCHOLOGICAL MEDICINE. 2023;53(4):1224-1232
Labour market marginalisation in young adults diagnosed with attention-deficit hyperactivity disorder (ADHD): a population-based longitudinal cohort study in Sweden
Helgesson M; Bjorkenstam E; Rahman S; Gustafsson K; Taipale H; Tanskanen A; Ekselius L; Mittendorfer-Rutz E
Article: BJPSYCH OPEN. 2023;9(2):e40
Patient factors associated with receipt of psychological and pharmacological treatments among individuals with common mental disorders in a Swedish primary care setting
Cullen AE; Lindsater E; Rahman S; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Helgesson M
Article: JOURNAL OF ALZHEIMERS DISEASE. 2023;90(4):1283-1290
The Cumulative Use of Muscle Relaxants and the Risk of Alzheimer's Disease: A Nationwide Case-Control Study
Rahkonen A; Taipale H; Koponen M; Hartikainen S; Tolppanen A-M; Tanskanen A; Tiihonen M
Article: PSYCHOLOGICAL MEDICINE. 2023;53(3):833-843
Continuity of antipsychotic medication use among migrant and Finnish-born populations with a psychotic disorder: a register-based study
Lehti V; Taipale H; Gissler M; Tanskanen A; Elonheimo M; Tiihonen J; Suvisaari J
Article: JOURNAL OF AFFECTIVE DISORDERS. 2023;321:28-32
Psychotic depression and deaths due to suicide
Paljarvi T; Tiihonen J; Lateenvuo M; Tanskanen A; Fazel S; Taipale H
Article: SCHIZOPHRENIA BULLETIN. 2023;49(1):78-89
Antipsychotic Use and Risk of Low-Energy Fractures in People With Schizophrenia: A Nationwide Nested Case-Control Study in Finland
Solmi M; Lahteenvuo M; Correll CU; Tanskanen A; Tiihonen J; Taipale H
Article: SCHIZOPHRENIA BULLETIN. 2023;49(1):136-143
Women with Schizophrenia-Spectrum Disorders After Menopause: A Vulnerable Group for Relapse
Sommer IE; Brand BA; Gangadin S; Tanskanen A; Tiihonen J; Taipale H
Article: JAMA PSYCHIATRY. 2023;80(1):31-39
Association of Pharmacological Treatments and Hospitalization and Death in Individuals With Amphetamine Use Disorders in a Swedish Nationwide Cohort of 13 965 Patients
Heikkinen M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Lahteenvuo M; Tiihonen J
Article: BRITISH JOURNAL OF PSYCHIATRY. 2023;222(1):37-43
Mortality in psychotic depression: 18-year follow-up study
Paljarvi T; Tiihonen J; Lahteenvuo M; Tanskanen A; Fazel S; Taipale H
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2022;146(6):583-593
Twenty-year medication use trends in first-episode bipolar disorder
Poranen J; Koistinaho A; Tanskanen A; Tiihonen J; Taipale H; Lahteenvuo M
Article: BRITISH JOURNAL OF PSYCHIATRY. 2022;221(6):758-765
Associations between antipsychotic use, substance use and relapse risk in patients with schizophrenia: real-world evidence from two national cohorts
Laehteenvuo M; Luykx JJ; Taipale H; Mittendorfer-Rutz E; Tanskanen A; Batalla A; Tiihonen J
Article: AMERICAN JOURNAL OF PSYCHIATRY. 2022;179(12):938-946
Effectiveness of Antipsychotic Use for Reducing Risk of Work Disability: Results From a Within-Subject Analysis of a Swedish National Cohort of 21,551 Patients With First-Episode Nonaffective Psychosis
Solmi M; Taipale H; Holm M; Tanskanen A; Mittendorfer-Rutz E; Correll CU; Tiihonen J
Article: JOURNAL OF AFFECTIVE DISORDERS. 2022;313:43-48
Allopurinol, dipyridamole and calcium channel blockers in the treatment of bipolar disorder - A nationwide cohort study
Lintunen J; Lahteenvuo M; Tanskanen A; Tiihonen J; Taipale H
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2022;61:36-42
Comparative effectiveness of mood stabilizers and antipsychotics in the prevention of hospitalization after lithium discontinuation in bipolar disorder
Holm M; Tanskanen A; Lahteenvuo M; Tiihonen J; Taipale H
Article: BMC PSYCHIATRY. 2022;22(1):484
Healthcare utilization, costs, and productivity losses in treatment-resistant depression in Finland - a matched cohort study
Taipale H; Lahteenvuo M; Tanskanen A; Huoponen S; Rannanpaa S; Tiihonen J
Article: JOURNAL OF AFFECTIVE DISORDERS. 2022;308:236-242
Courses of treatment and risk factors for treatment-resistant depression in Finnish primary and special healthcare: A nationwide cohort study
Lahteenvuo M; Taipale H; Tanskanen A; Rannanpaa S; Tiihonen J
Article: SCHIZOPHRENIA BULLETIN. 2022;48(4):774-784
Optimal Doses of Specific Antipsychotics for Relapse Prevention in a Nationwide Cohort of Patients with Schizophrenia
Taipale H; Tanskanen A; Luykx JJ; Solmi M; Leucht S; Correll CU; Tiihonen J
Article: INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. 2022;19(12):7254
Occupational Branch and Labor Market Marginalization among Young Employees with Adult Onset of Attention Deficit Hyperactivity Disorder-A Population-Based Matched Cohort Study
Gemes K; Bjorkenstam E; Rahman S; Gustafsson K; Taipale H; Tanskanen A; Ekselius L; Mittendorfer-Rutz E; Helgesson M
Article: ADDICTION. 2022;117(6):1683-1691
Real-world effectiveness of pharmacological treatments of opioid use disorder in a national cohort
Heikkinen M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Lahteenvuo M; Tiihonen J
Article: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 2022;23(6):1059-1065.e4
Antipsychotic Use and Risk of Stroke Among Community-Dwelling People With Alzheimer's Disease
Koponen M; Rajamaki B; Lavikainen P; Bell JS; Taipale H; Tanskanen A; Hartikainen S; Tolppanen A-M
Article: BMC GERIATRICS. 2022;22(1):464
Prevalence of oral anticoagulant use among people with and without Alzheimer's disease
Babar BA; Vu M; Koponen M; Taipale H; Tanskanen A; Kettunen R; Tiihonen M; Hartikainen S; Tolppanen A-M
Article: SCHIZOPHRENIA BULLETIN. 2022;48(3):655-663
Primary Nonadherence to Antipsychotic Treatment Among Persons with Schizophrenia
Lieslehto J; Tiihonen J; Lahteenvuo M; Tanskanen A; Taipale H
Article: LANCET PSYCHIATRY. 2022;9(5):353-362
Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland
Tiihonen J; Tanskanen A; Bell JS; Dawson JL; Kataja V; Taipale H
Article: LANCET PSYCHIATRY. 2022;9(4):271-279
Real-world effectiveness of antipsychotic doses for relapse prevention in patients with first-episode schizophrenia in Finland: a nationwide, register-based cohort study
Taipale H; Tanskanen A; Correll CU; Tiihonen J
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2022;78(3):513-521
Automated multi-dose dispensing in persons with and without Alzheimer's disease-impacts on pharmacotherapy
Vallius S; Taipale H; Koponen M; Tolppanen A-M; Tanskanen A; Hartikainen S; Tiihonen M
Article: JOURNAL OF ATTENTION DISORDERS. 2022;26(5):723-734
Risk Factors for Disability Pension among Young Adults Diagnosed with Attention-deficit Hyperactivity Disorder (ADHD) in Adulthood
Chen L; Mittendorfer-Rutz E; Bjorkenstam E; Rahman S; Gustafsson K; Taipale H; Tanskanen A; Ekselius L; Helgesson M
Article: SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY. 2022;57(3):595-600
Maternal smoking during pregnancy and offspring psychiatric disorder: a longitudinal birth cohort study
Brannigan R; Tanskanen A; Huttunen MO; Cannon M; Leacy FP; Clarke MC
Article: JAMA PSYCHIATRY. 2022;79(3):210-218
Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials
Taipale H; Schneider-Thoma J; Pinzon-Espinosa J; Radua J; Efthimiou O; Vinkers CH; Mittendorfer-Rutz E; Cardoner N; Pintor L; Tanskanen A; Tomlinson A; Fusar-Poli P; Cipriani A; Vieta E; Leucht S; Tiihonen J; Luykx JJ
Article: SCHIZOPHRENIA BULLETIN. 2022;48(1):166-175
Antipsychotics Use Is Associated With Greater Adherence to Cardiometabolic Medications in Patients With Schizophrenia: Results From a Nationwide, Within-subject Design Study
Solmi M; Tiihonen J; Lahteenvuo M; Tanskanen A; Correll CU; Taipale H
Article: JOURNAL OF AFFECTIVE DISORDERS. 2021;295:1474-1481
Switches and early discontinuations of antidepressant medication in young adults with depression
Lampela P; Tanskanen A; Lahteenvuo M; Tiihonen J; Taipale H
Article: JOURNAL OF AFFECTIVE DISORDERS. 2021;294:831-837
Persistence of antidepressant use among refugee youth with common mental disorder
Taipale H; Niederkrotenthaler T; Tanskanen A; Cullen AE; Helgesson M; Berg L; Sijbrandij M; Klimek P; Mittendorfer-Rutz E
Article: EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES. 2021;30:e67
Trajectories of labour market marginalisation among young adults with newly diagnosed attention-deficit/hyperactivity disorder (ADHD)
Helgesson M; Rahman S; Bjorkenstam E; Gustafsson K; Amin R; Taipale H; Tanskanen A; Ekselius L; Mittendorfer-Rutz E
Article: SCHIZOPHRENIA BULLETIN. 2021;47(6):1611-1620
Long-term Continuity of Antipsychotic Treatment for Schizophrenia: A Nationwide Study
Rubio JM; Taipale H; Tanskanen A; Correll CU; Kane JM; Tiihonen J
Article: SCHIZOPHRENIA BULLETIN. 2021;47(6):1621-1630
Risk Factors, Incidence, and Outcomes of Neuroleptic Malignant Syndrome on Long-Acting Injectable vs Oral Antipsychotics in a Nationwide Schizophrenia Cohort
Guinart D; Taipale H; Rubio JM; Tanskanen A; Correll CU; Tiihonen J; Kane JM
Article: LANCET PSYCHIATRY. 2021;8(10):883-891
Antipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland
Taipale H; Solmi M; Lahteenvuo M; Tanskanen A; Correll CU; Tiihonen J
Article: ADDICTION. 2021;116(8):1990-1998
Real-world effectiveness of pharmacological treatments of alcohol use disorders in a Swedish nation-wide cohort of 125 556 patients
Heikkinen M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Lahteenvuo M; Tiihonen J
Article: SCHIZOPHRENIA BULLETIN. 2021;47(4):1099-1107
Long-Term Real-World Effectiveness of Pharmacotherapies for Schizoaffective Disorder
Lintunen J; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Tiihonen J; Lahteenvuo M
Article: ARCHIVES OF SUICIDE RESEARCH. 2021;25(3):424-438
Risk Factors for Suicide and Suicide Attempts Among Patients With Treatment-Resistant Depression: Nested Case-Control Study
Reutfors J; Andersson TM-L; Tanskanen A; DiBernardo A; Li G; Brandt L; Brenner P
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2021;144(1):42-49
Morbidity and mortality in schizophrenia with comorbid substance use disorders
Lahteenvuo M; Batalla A; Luykx JJ; Mittendorfer-Rutz E; Tanskanen A; Tiihonen J; Taipale H
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2021;36(7):1075-1084
Association of recent hospitalisation with antidepressant initiation among community dwellers with Alzheimer's disease
Tarvainen A; Hartikainen S; Taipale H; Tanskanen A; Koponen M; Tolppanen A-M
Article: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 2021;22(7):1543-1547.e3
Does Recent Hospitalization Increase Antipsychotic Initiation Among Community Dwellers With Alzheimer's Disease?
Hakala A; Tolppanen A-M; Koponen M; Taipale H; Tanskanen A; Hartikainen S; Tiihonen M
Article: NORDIC JOURNAL OF PSYCHIATRY. 2021;75(5):315-322
Antipsychotic use among persons with schizophrenia in Sweden and Finland, trends and differences
Taipale H; Puranen A; Mittendorfer-Rutz E; Tiihonen J; Tanskanen A; Cervenka S; Lahteenvuo M
Article: SCHIZOPHRENIA RESEARCH. 2021;232:33-41
Molecular signaling pathways underlying schizophrenia
Tiihonen J; Koskuvi M; Lahteenvuo M; Trontti K; Ojansuu I; Vaurio O; Cannon DT; Lonnqvist J; Therman S; Suvisaari J; Cheng L; Tanskanen A; Taipale H; Lehtonen A; Koistinaho J
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2021;143(6):487-494
Incidence of schizophrenia and influence of prenatal and infant exposure to viral infectious diseases
Tanskanen A; Taipale H; Cannon M; Cotter D; Tiihonen J
Article: CLINICAL EPIDEMIOLOGY. 2021;13:295-307
Hip Fracture Risk in Antiepileptic Drug Initiators and Non-Initiators with Alzheimer's Disease
Pisa F; Reinold J; Lavikainen P; Koponen M; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen A-M
Article: SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY. 2021;56(3):463-474
Initiation of antidepressant use among refugee and Swedish-born youth after diagnosis of a common mental disorder: findings from the REMAIN study
Taipale H; Niederkrotenthaler T; Helgesson M; Sijbrandij M; Berg L; Tanskanen A; Mittendorfer-Rutz E
Article: SCHIZOPHRENIA RESEARCH. 2021;228:367-372
Effectiveness of pharmacotherapies for delusional disorder in a Swedish national cohort of 9076 patients
Lahteenvuo M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Tiihonen J
Article: SCHIZOPHRENIA BULLETIN. 2021;47(1):23-30
Comparative Effectiveness of Antipsychotics for Risk of Attempted or Completed Suicide Among Persons With Schizophrenia
Taipale H; Lahteenvuo M; Tanskanen A; Mittendorfer-Rutz E; Tiihonen J
Article: NPJ SCHIZOPHRENIA. 2021;7(1):1
Adenosine modulators and calcium channel blockers as add-on treatment for schizophrenia
Lintunen J; Lahteenvuo M; Tiihonen J; Tanskanen A; Taipale H
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2021;143(1):61-71
Employment among people with schizophrenia or bipolar disorder: A population-based study using nationwide registers
Holm M; Taipale H; Tanskanen A; Tiihonen J; Mitterdorfer-Rutz E
Article: JOURNAL OF AFFECTIVE DISORDERS. 2020;277:885-892
Suicide mortality and use of psychotropic drugs in patients hospitalized due to bipolar disorder: A Finnish nationwide cohort study
Antolin-Concha D; Lahteenvuo M; Vattulainen P; Tanskanen A; Taipale H; Vieta E; Tiihonen J
Article: CTS-CLINICAL AND TRANSLATIONAL SCIENCE. 2020;13(6):1170-1177
Persistence of Antipsychotic Use After Clozapine Discontinuation: A Real-World Study Across Antipsychotics
Stam N; Taipale H; Tanskanen A; Isphording L; Okhuijsen-Pfeifer C; Schuiling-Veninga CCM; Bos JHJ; Bijker BJ; Tiihonen J; Luykx JJ
Article: JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES. 2020;75(11):2184-2192
Length of Hospital Stay for Hip Fracture and 30-Day Mortality in People With Alzheimer's Disease: A Cohort Study in Finland
Lavikainen P; Koponen M; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen A-M
Article: JAMA NETWORK OPEN. 2020;3(10):e2019029
Incidence of and Characteristics Associated With Long-term Benzodiazepine Use in Finland
Taipale H; Sarkila H; Tanskanen A; Kurko T; Taiminen T; Tiihonen J; Sund R; Tuulio-Henriksson A; Saastamoinen L; Hietala J
Article: MEDICAL CARE. 2020;58(9):763-769
Medication Use and Health Care Utilization After a Cost-sharing Increase in Schizophrenia A Nationwide Analysis
Hamina A; Tanskanen A; Tiihonen J; Taipale H
Article: INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS. 2020;141:104142
Detection of medications associated with Alzheimer's disease using ensemble methods and cooperative game theory
Braithwaite B; Paananen J; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen A-M
Article: BRITISH JOURNAL OF PSYCHIATRY. 2020;217(3):498-505
In the aftermath of clozapine discontinuation: comparative effectiveness and safety of antipsychotics in patients with schizophrenia who discontinue clozapine
Luykx JJ; Stam N; Tanskanen A; Tiihonen J; Taipale H
Article: PSYCHOLOGICAL MEDICINE. 2020;50(8):1356-1367
Psychosis breakthrough on antipsychotic maintenance: results from a nationwide study
Rubio JM; Taipale H; Correll CU; Tanskanen A; Kane JM; Tiihonen J
Article: NEUROLOGY. 2020;94(20):e2099-e2108
Antiepileptic drug use and mortality among community-dwelling persons with Alzheimer disease
Sarycheva T; Lavikainen P; Taipale H; Tiihonen J; Tanskanen A; Hartikainen S; Tolppanen A-M
Article: BMC PSYCHIATRY. 2020;20(1):232
Risk and risk factors for disability pension among patients with treatment resistant depression- a matched cohort study
Taipale H; Reutfors J; Tanskanen A; Brandt L; Tiihonen J; DiBernardo A; Mittendorfer-Rutz E; Brenner P
Article: NPJ SCHIZOPHRENIA. 2020;6(1):12
The clinical course of schizophrenia in women and men-a nation-wide cohort study
Sommer IE; Tiihonen J; van Mourik A; Tanskanen A; Taipale H
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2020;76(5):711-718
Use of antidepressants and mood stabilizers in persons with first-episode schizophrenia
Puranen A; Koponen M; Tanskanen A; Tiihonen J; Taipale H
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2020;105(4):dgz234-e972
Metformin and Risk of Alzheimer's Disease Among Community-Dwelling People With Diabetes: A National Case-Control Study
Sluggett JK; Koponen M; Bell JS; Taipale H; Tanskanen A; Tiihonen J; Uusitupa M; Tolppanen A-M; Hartikainen S
Article: JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. 2020;68(3):595-602
The Risk of Head Injuries Associated With Antipsychotic Use Among Persons With Alzheimer's disease
Tapiainen V; Lavikainen P; Koponen M; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen A-M
Article: DRUGS & AGING. 2020;37(3):193-203
Opioid Use After Hospital Care due to Hip Fracture Among Community-Dwelling Persons With and Without Alzheimer's Disease
Lintula E; Tiihonen M; Taipale H; Tolppanen A-M; Tanskanen A; Tiihonen J; Hartikainen S; Hamina A
Article: JOURNAL OF ALZHEIMERS DISEASE. 2020;73(3):1243-1251
Asthma and Chronic Obstructive Pulmonary Disease as a Comorbidity and Association with the Choice of Antidementia Medication Among Persons with Alzheimer's Disease
Lampela P; Tolppanen A-M; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
Article: WORLD PSYCHIATRY. 2020;19(1):61-68
20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20)
Taipale H; Tanskanen A; Mehtala J; Vattulainen P; Correll CU; Tiihonen J
Article: SCHIZOPHRENIA RESEARCH. 2020;216:229-234
Childhood temperament and its association with adult psychiatric disorders in a prospective cohort study
Brannigan R; Cannon M; Tanskanen A; Huttunen MO; Leacy FP; Clarke MC
Article: INTERNATIONAL JOURNAL OF CARDIOLOGY. 2020;300:221-225
Prevalence of cardiovascular drug use before and after diagnosis of Alzheimer's disease
Vu M; Koponen M; Taipale H; Tanskanen A; Tiihonen J; Kettunen R; Hartikainen S; Tolppanen A-M
Article: BRITISH JOURNAL OF PSYCHIATRY. 2020;216(2):85-89
The role of prenatal stress as a pathway to personality disorder: longitudinal birth cohort study
Brannigan R; Tanskanen A; Huttunen MO; Cannon M; Leacy FP; Clarke MC
Article: SCIENTIFIC REPORTS. 2020;10(1):1219
Health and work disability outcomes in parents of patients with schizophrenia associated with antipsychotic exposure by the offspring
Taipale H; Rahman S; Tanskanen A; Mehtala J; Hoti F; Jedenius E; Enkusson D; Leval A; Sermon J; Tiihonen J; Mittendorfer-Rutz E
Article: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 2019;20(12):1488-1494.e3
Accumulation of Hospital Days Among Antipsychotic Initiators With Alzheimer's Disease
Koponen M; Lavikainen P; Taipale H; Lic ATP; Tiihonen J; Hartikainen S; Tolppanen A-M
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2019;75(10):1421-1430
Adherence to psychotropic medication in completed suicide in Sweden 2006-2013: a forensic-toxicological matched case-control study
Forsman J; Taipale H; Masterman T; Tiihonen J; Tanskanen A
Article: ANNALS OF MEDICINE. 2019;51(5-6):294-305
Predictors of high hospital care and medication costs and cost trajectories in community-dwellers with Alzheimer's disease
Kalamagi J; Lavikainen P; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen A-M
Article: OSTEOPOROSIS INTERNATIONAL. 2019;30(7):1481-1489
Long-term thiazide use and risk of low-energy fractures among persons with Alzheimer's disease-nested case-control study
Taipale H; Rysa J; Hukkanen J; Koponen M; Tanskanen A; Tiihonen J; Kroger H; Hartikainen S; Tolppanen A-M
Article: SCHIZOPHRENIA BULLETIN. 2019;45(4):794-803
Burden for Parents of Patients With Schizophrenia-A Nationwide Comparative Study of Parents of Offspring With Rheumatoid Arthritis, Multiple Sclerosis, Epilepsy, and Healthy Controls
Mittendorfer-Rutz E; Rahman S; Tanskanen A; Majak M; Mehtala J; Hoti F; Jedenius E; Enkusson D; Leval A; Sermon J; Taipale H; Tiihonen J
Article: JOURNAL OF ALZHEIMERS DISEASE. 2019;69(3):807-816
Hospital-Treated Pneumonia Associated with Opioid Use Among Community Dwellers with Alzheimer's Disease
Hamina A; Taipale H; Karttunen N; Tanskanen A; Tiihonen J; Tolppanen A-M; Hartikainen S
Article: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 2019;20(6):751-758
Antiepileptic Drugs and Accumulation of Hospital Days Among Persons With Alzheimer's Disease
Lavikainen P; Taipale H; Tanskanen A; Koponen M; Tiihonen J; Hartikainen S; Tolppanen A-M
Article: JAMA PSYCHIATRY. 2019;76(5):499-507
Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia
Tiihonen J; Taipale H; Mehtala J; Vattulainen P; Correll CU; Tanskanen A
Article: JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH. 2019;73(5):451-454
Incidence of head injury and traumatic brain injury among people with Alzheimer's disease
Ilmaniemi S; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen A-M
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2019;139(4):304-310
The association between subjective maternal stress during pregnancy and offspring clinically diagnosed psychiatric disorders
Brannigan R; Cannon M; Tanskanen A; Huttunen MO; Leacy FP; Clarke MC
Article: JOURNAL OF ALZHEIMERS DISEASE. 2019;68(1):127-136
Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study
Taipale H; Lampela P; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen A-M
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2019;75(3):417-425
Duration of new antidepressant use and factors associated with discontinuation among community-dwelling persons with Alzheimer's disease
Kettunen R; Taipale H; Tolppanen A-M; Tanskanen A; Tiihonen J; Hartikainen S; Koponen M
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2019;34(2):280-288
Concomitant use of benzodiazepines and opioids in community-dwelling older people with or without Alzheimer's disease-A nationwide register-based study in Finland
Karttunen N; Taipale H; Hamina A; Tanskanen A; Tiihonen J; Tolppanen A-M; Hartikainen S
Article: PAIN. 2019;160(2):417-423
Incident opioid use and risk of hip fracture among persons with Alzheimer disease: a nationwide matched cohort study
Taipale H; Hamina A; Karttunen N; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen A-M
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2018;138(6):492-499
Mortality in schizophrenia: 30-year nationwide follow-up study
Tanskanen A; Tiihonen J; Taipale H
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2018;28(11):1260-1269
Psychotropic drugs use and psychotropic polypharmacy among persons with Alzheimer's disease
Orsel K; Taipale H; Tolppanen A-M; Koponen M; Tanskanen A; Tiihonen J; Gardarsdottir H; Hartikainen S
Article: BIPOLAR DISORDERS. 2018;20(7):634-646
Initiation and long-term use of benzodiazepines and Z-drugs in bipolar disorder
Wingard L; Taipale H; Reutfors J; Westerlund A; Boden R; Tiihonen J; Tanskanen A; Andersen M
Article: PAIN MEDICINE. 2018;19(11):2115-2121
Is Alzheimer's Disease Associated with Previous Opioid Use?
Taipale H; Hamina A; Lampela P; Tanskanen A; Tiihonen J; Karttunen N; Tolppanen A-M; Hartikainen S
Article: DRUGS & AGING. 2018;35(11):985-992
Systemic Estrogen Use and Discontinuation After Alzheimer's Disease Diagnosis in Finland 2005-2012: A Nationwide Exposure-Matched Cohort Study
Tolppanen A-M; Tiihonen M; Taipale H; Koponen M; Tanskanen A; Lavikainen P; Tiihonen J; Hartikainen S
Article: SCHIZOPHRENIA BULLETIN. 2018;44(6):1381-1387
Comparative Effectiveness of Antipsychotic Drugs for Rehospitalization in Schizophrenia-A Nationwide Study With 20-Year Follow-up
Taipale H; Mehtala J; Tanskanen A; Tiihonen J
Article: JOURNAL OF ALZHEIMERS DISEASE. 2018;66(1):387-395
Incidence and Prevalence of Antiepileptic Medication Use in Community-Dwelling Persons with and without Alzheimer's Disease
Sarychevaa T; Taipale H; Lavikainen P; Tiihonen J; Tanskanen A; Hartikainen S; Tolppanen A-M
Article: JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. 2018;38(5):494-497
Antipsychotic Use and the Risk of Initiating Medication for Benign Prostate Hyperplasia in Persons With Alzheimer Disease: A Matched Cohort Study
Orsel K; Taipale H; Raatikainen S; Lampela P; Tolppanen A-M; Koponen M; Tanskanen A; Tiihonen J; Gardarsdottir H; Hartikainen S
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2018;27(10):1112-1122
Comparison of dispensed medications and forensic-toxicological findings to assess pharmacotherapy in the Swedish population 2006 to 2013
Forsman J; Taipale H; Masterman T; Tiihonen J; Tanskanen A
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2018;7(18):e009742
Antiepileptic Drug Use and the Risk of Stroke Among Community-Dwelling People With Alzheimer Disease: A Matched Cohort Study
Sarycheva T; Lavikainen P; Taipale H; Tiihonen J; Tanskanen A; Hartikainen S; Tolppanen A-M
Article: AMERICAN JOURNAL OF PSYCHIATRY. 2018;175(8):765-773
20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia
Tiihonen J; Tanskanen A; Taipale H
Article: ACTA PSYCHIATRICA SCANDINAVICA. 2018;138(2):91-100
The risk of Alzheimer's disease associated with benzodiazepines and related drugs: a nested case-control study
Tapiainen V; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen A-M
Article: JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. 2018;66(6):1123-1129
Use of Antiepileptic Drugs and Dementia Riskan Analysis of Finnish Health Register and German Health Insurance Data
Taipale H; Gomm W; Broich K; Maier W; Tolppanen A-M; Tanskanen A; Tiihonen J; Hartikainen S; Haenisch B
Article: INTERNATIONAL PSYCHOGERIATRICS. 2018;30(7):947-956
Impact of opioid initiation on antipsychotic and benzodiazepine and related drug use among persons with Alzheimer's disease
Hamina A; Lavikainen P; Tanskanen A; Tolppanen A-M; Tiihonen J; Hartikainen S; Taipale H
Article: SCHIZOPHRENIA RESEARCH. 2018;197:274-280
Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia
Taipale H; Mittendorfer-Rutz E; Alexanderson K; Majak M; Mehtala J; Hoti F; Jedenius E; Enkusson D; Leval A; Sermon J; Tanskanen A; Tiihonen J
Article: JOURNAL OF ALZHEIMERS DISEASE. 2018;64(2):437-445
Hospitalization after Oral Antibiotic Initiation in Finnish Community Dwellers with and without Alzheimer's Disease: Retrospective Register-Based Cohort Study
Jarvinen H; Taipale H; Koponen M; Tanskanen A; Tiihonen J; Tolppanen A-M; Hartikainen S
Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2018;47(8):1135-1142
Proton pump inhibitor use and risk of hip fractures among community-dwelling persons with Alzheimer's disease-a nested case-control study
Torvinen-Kiiskinen S; Tolppanen A-M; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
Article: JAMA PSYCHIATRY. 2018;75(4):347-355
Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder
Lahteenvuo M; Tanskanen A; Taipale H; Hoti F; Vattulainen P; Vieta E; Tiihonen J
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2018;33(4):583-590
Risk of death associated with new benzodiazepine use among persons with Alzheimer disease: A matched cohort study
Saarelainen L; Tolppanen A-M; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
Article: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 2018;19(3):193-199
Research Priorities for Optimizing Geriatric Pharmacotherapy: An International Consensus
Tan ECK; Sluggett JK; Johnell K; Onder G; Elseviers M; Morin L; Vetrano DL; Wastesson JW; Fastbom J; Taipale H; Tanskanen A; Bell JS
Article: BMC PSYCHIATRY. 2018;18(1):47
Trajectories of antidepressant medication use in individuals before and after being granted disability pension due to common mental disorders- a nationwide register-based study
Rahman S; Wiberg M; Alexanderson K; Jokinen J; Tanskanen A; Mittendorfer-Rutz E
Article: ORNIS FENNICA. 2018;95(2):49-60
Can common forest bird species tolerate disturbances in neighbouring areas? A case study of the Vuosaari Harbour construction in southern Finland
Yrjola RA; Tanskanen A; Sarvanne H; Vickholm J; Lehikoinen A
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2017;32(12):e107-e115
Antidepressant use and risk of hip fractures among community-dwelling persons with and without Alzheimer's disease
Torvinen-Kiiskinen S; Tolppanen A-M; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
Article: AMERICAN JOURNAL OF GASTROENTEROLOGY. 2017;112(12):1802-1808
No Association Between Proton Pump Inhibitor Use and Risk of Alzheimer's Disease
Taipale H; Tolppanen A-M; Tiihonen M; Tanskanen A; Tiihonen J; Hartikainen S
Article: PLOS ONE. 2017;12(9):e0184070
Drug exposure in register-based research-An expert-opinion based evaluation of methods
Tanskanen A; Taipale H; Koponen M; Tolppanen A-M; Hartikainen S; Ahonen R; Tiihonen J
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2017;73(9):1149-1158
Long-term use of proton pump inhibitors among community-dwelling persons with and without Alzheimer's disease
Juntunen H; Taipale H; Tanskanen A; Tolppanen A-M; Tiihonen J; Hartikainen S; Tiihonen M
Article: ANNALS OF PHARMACOTHERAPY. 2017;51(9):725-734
Incident Use of a Potentially Inappropriate Medication and Hip Fracture in Community-Dwelling Older Persons With Alzheimer's Disease
Hyttinen V; Taipale H; Tolppanen A-M; Tanskanen A; Tiihonen J; Hartikainen S; Valtonen H
Article: ALZHEIMERS RESEARCH & THERAPY. 2017;9(1):59
Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer's disease: a nationwide matched cohort study
Taipale H; Koponen M; Tanskanen A; Lavikainen P; Sund R; Tiihonen J; Hartikainen S; Tolppanen A-M
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2017;26(8):875-889
Screening approach for identifying candidate drugs and drug-drug interactions related to hip fracture risk in persons with Alzheimer disease
Tolppanen A-M; Taipale H; Koponen M; Tanskanen A; Lavikainen P; Paananen J; Tiihonen J; Hartikainen S
Article: JOURNAL OF AFFECTIVE DISORDERS. 2017;217:16-23
Reducing the rehospitalization risk after a manic episode: A population based cohort study of lithium, valproate, olanzapine,quetiapine and aripiprazole in monotherapy and combinations
Wingard L; Boden R; Brandt L; Tiihonen J; Tanskanen A; Kieler H; Andersen M; Reutfors J
Article: JAMA PSYCHIATRY. 2017;74(7):686-693
Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia
Tiihonen J; Mittendorfer-Rutz E; Majak M; Mehtala J; Hoti F; Jedenius E; Enkusson D; Leval A; Sermon J; Tanskanen A; Taipale H
Article: LANCET PSYCHIATRY. 2017;4(7):547-553
Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort study
Tiihonen J; Tanskanen A; Hoti F; Vattulainen P; Taipale H; Mehtala J; Lahteenvuo M
Article: INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY. 2017;32(3):135-141
Use of benzodiazepines and related drugs is associated with a risk of stroke among persons with Alzheimer's disease
Taipale H; Koponen M; Tanskanen A; Lavikainen P; Tolppanen A-M; Sund R; Tiihonen J; Hartikainen S
Article: CANADIAN MEDICAL ASSOCIATION JOURNAL. 2017;189(14):E519-E529
Risk of pneumonia associated with incident benzodiazepine use among community-dwelling adults with Alzheimer disease
Taipale H; Tolppanen A-M; Koponen M; Tanskanen A; Lavikainen P; Sund R; Tiihonen J; Hartikainen S
Article: ANNALS OF MEDICINE. 2017;49(3):230-239
Use of antidementia drugs and risk of pneumonia in older persons with Alzheimer's disease
Lampela P; Tolppanen A-M; Tanskanen A; Tiihonen J; Lavikainen P; Hartikainen S; Taipale H
Article: EUROPEAN JOURNAL OF PAIN. 2017;21(4):658-667
Differences in analgesic use in community-dwelling persons with and without Alzheimer's disease
Hamina A; Taipale H; Tanskanen A; Tolppanen A-M; Tiihonen J; Hartikainen S
Article: MATURITAS. 2017;98:7-13
Risk of Alzheimer's disease among users of postmenopausal hormone therapy: A nationwide case-control study
Irntiaz B; Taipale H; Tanskanen A; Tiihonen M; Kivipelto M; Heikkinen A-M; Tiihonen J; Soininen H; Hartikainen S; Tolppanen A-M
Article: JOURNAL OF CLINICAL PSYCHIATRY. 2017;78(3):e257-e263
Antipsychotic Use and the Risk of Hip Fracture Among Community-Dwelling Persons With Alzheimer's Disease
Koponen M; Taipale H; Lavikainen P; Tanskanen A; Tiihonen J; Tolppanen A-M; Ahonen R; Hartikainen S
Article: PLOS ONE. 2017;12(3):e0173450
Regional changes in psychotropic use among Finnish persons with newly diagnosed Alzheimer's disease in 2005-2011
Tolppanen A-M; Voutilainen A; Taipale H; Tanskanen A; Lavikainen P; Koponen M; Tiihonen J; Hartikainen S
Article: PAIN. 2017;158(2):252-260
Long-term use of opioids for nonmalignant pain among community-dwelling persons with and without Alzheimer disease in Finland: a nationwide register-based study
Hamina A; Taipale H; Tanskanen A; Tolppanen A-M; Karttunen N; Pylkkanen L; Tiihonen J; Hartikainen S
Article: JOURNAL OF ALZHEIMERS DISEASE. 2017;56(1):107-118
Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease
Koponen M; Taipale H; Lavikainen P; Tanskanen A; Tiihonen J; Tolppanen A-M; Ahonen R; Hartikainen S
Article: JOURNAL OF ALZHEIMERS DISEASE. 2017;56(1):119-128
Anticholinergic Exposure and Risk of Pneumonia in Persons with Alzheimer's Disease: A Nested Case-Control Study
Lampela P; Tolppanen A-M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
Article: DRUGS & AGING. 2017;34(1):55-65
A Comparison of Sex Differences in Psychotropic Medication Use in Older People with Alzheimer's Disease in the US and Finland
Moga DC; Taipale H; Tolppanen A-M; Tanskanen A; Tiihonen J; Hartikainen S; Wu Q; Jicha GA; Gnjidic D
Article: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 2017;18(1):87.e15-87.e21
Risk of Hip Fracture in Benzodiazepine Users With and Without Alzheimer Disease
Saarelainen L; Tolppanen A-M; Koponen M; Phil AT; Sund R; Tiihonen J; Hartikainen S; Taipale H
Article: DRUGS & AGING. 2017;34(1):67-77
Risk Factors for Initiation of Potentially Inappropriate Medications in Community-Dwelling Older Adults with and without Alzheimer's Disease
Hyttinen V; Taipale H; Tanskanen A; Tiihonen J; Tolppanen A-M; Hartikainen S; Valtonen H
Article: INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY. 2017;32(1):94-101
Incidence of antidepressant use in community-dwelling persons with and without Alzheimer's disease: 13-year follow-up
Puranen A; Taipale H; Koponen M; Tanskanen A; Tolppanen A-M; Tiihonen J; Hartikainen S
Article: ANNALES ZOOLOGICI FENNICI. 2016;53(5-6):241-254
Effects of human activities on populations of wetland birds: a case study from Vuosaari Harbour, southern Finland
Yrjola RA; Tanskanen A; Sarvanne H; Vickholm J; Santaharju JLM
Article: CHEST. 2016;150(6):1233-1241
Antipsychotic Use and Risk of Hospitalization or Death Due to Pneumonia in Persons With and Those Without Alzheimer Disease
Tolppanen A-M; Koponen M; Tanskanen A; Lavikainen P; Sund R; Tiihonen J; Hartikainen S; Taipale H
Article: BMC GERIATRICS. 2016;16(1):204
Comparison of predictors of hip fracture and mortality after hip fracture in community-dwellers with and without Alzheimer's disease - exposure-matched cohort study
Tolppanen A-M; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S
Article: AGE AND AGEING. 2016;45(6):900-904
Drug use in persons with and without Alzheimer's disease aged 90 years or more
Taipale H; Koponen M; Tanskanen A; Tolppanen A-M; Tiihonen J; Hartikainen S
Article: CLINICAL EPIDEMIOLOGY. 2016;8:363-371
Agreement between PRE2DUP register data modeling method and comprehensive drug use interview among older persons
Taipale H; Tanskanen A; Koponen M; Tolppanen A-M; Tiihonen J; Hartikainen S
Article: BMJ OPEN. 2016;6(7):e012100
Cohort profile: the Finnish Medication and Alzheimer's disease (MEDALZ) study
Tolppanen A-M; Taipale H; Koponen M; Lavikainen P; Tanskanen A; Tiihonen J; Hartikainen S
Article: AMERICAN JOURNAL OF PSYCHIATRY. 2016;173(6):600-606
Mortality and Cumulative Exposure to Antipsychotics, Antidepressants, and Benzodiazepines in Patients With Schizophrenia: An Observational Follow-Up Study
Tiihonen J; Mittendorfer-Rutz E; Torniainen M; Alexanderson K; Tanskanen A
Article: JOURNAL OF ALZHEIMERS DISEASE. 2016;52(1):127-132
Incidence and Duration of Cumulative Bisphosphonate Use among Community-Dwelling Persons with or without Alzheimer's Disease
Tiihonen M; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S
Article: JOURNAL OF PREVENTIVE MEDICINE AND PUBLIC HEALTH. 2016;49(2):134-138
Month and Season of Birth as a Risk Factor for Alzheimer's Disease: A Nationwide Nested Case-control Study.
Tolppanen A-M; Ahonen R; Koponen M; Lavikainen P; Purhonen M; Taipale H; Tanskanen A; Tiihonen J; Tiihonen M; Hartikainen S
Article: SCANDINAVIAN JOURNAL OF PUBLIC HEALTH. 2016;44(2):150-158
Hospital care and drug costs from five years before until two years after the diagnosis of Alzheimer's disease in a Finnish nationwide cohort
Taipale H; Purhonen M; Tolppanen A-M; Tanskanen A; Tiihonen J; Hartikainen S
Article: DUODECIM; LAAKETIETEELLINEN AIKAKAUSKIRJA. 2016;132(2):181
[Mortality and cumulative exposure to antipsychotics, antidepressants and benzodiazepines in patients with schizophrenia: an observational follow-up study].
Tiihonenl J; Mittendorfer-Rutz E; Torniainen M; Alexanderson K; Tanskanen A
Article: JOURNAL OF ALZHEIMERS DISEASE. 2015;49(3):809-818
The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer's Disease
Saarelainen L; Taipale H; Koponen M; Tanskanen A; Tolppanen A-M; Tiihonen JI; Hartikainen S
Article: DRUGS & AGING. 2015;32(11):937-945
Prevalence of Drug Combinations Increasing Bleeding Risk Among Warfarin Users With and Without Alzheimer's Disease
Taipale H; Vuorikari H; Tanskanen A; Koponen M; Tiihonen J; Kettunen R; Hartikainen S
Article: BRITISH JOURNAL OF PSYCHIATRY. 2015;207(5):444-449
Incidence of antipsychotic use in relation to diagnosis of Alzheimer's disease among community-dwelling persons
Koponen M; Tolppanen A-M; Taipale H; Tanskanen A; Tiihonen J; Johnell K; Fastbom J; Ahonen R; Hartikainen S
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2015;25(10):1706-1713
Long-term use of antipsychotics among community-dwelling persons with Alzheimer's disease: A nationwide register-based study
Koponen M; Taipale H; Tanskanen A; Tolppanen A-M; Tiihonen J; Ahonen R; Hartikainen S
Article: JOURNAL OF AFFECTIVE DISORDERS. 2015;183:159-165
Lithium is associated with decrease in all-cause and suicide mortality in high-risk bipolar patients: A nationwide registry-based prospective cohort study
Toffol E; Hatonen T; Tanskanen A; Lonnqvist J; Wahlbeck K; Joffe G; Tiihonen J; Haukka J; Partonen T
Article: INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY. 2015;30(4):202-208
Long-term use of benzodiazepines and related drugs among community-dwelling individuals with and without Alzheimer's disease
Taipale H; Koponen M; Tanskanen A; Tolppanen A-M; Tiihonen J; Hartikainen S
Article: URBAN ECOSYSTEMS. 2015;18(2):341-354
Roadside and riverside green - urban corridors in the city of Vantaa, Finland
Ranta P; Kesulahti J; Tanskanen A; Viljanen V; Virtanen T
Article: SCHIZOPHRENIA BULLETIN. 2015;41(3):656-663
Antipsychotic Treatment and Mortality in Schizophrenia
Torniainen M; Mittendorfer-Rutz E; Tanskanen A; Bjorkenstam C; Suvisaari J; Alexanderson K; Tiihonen J
Article: BMC MEDICAL INFORMATICS AND DECISION MAKING. 2015;15:21
From prescription drug purchases to drug use periods - a second generation method (PRE2DUP)
Tanskanen A; Taipale H; Koponen M; Tolppanen A-M; Hartikainen S; Ahonen R; Tiihonen J
Article: JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. 2014;34(6):722-727
Concomitant Use of Acetylcholine Esterase Inhibitors and Urinary Antispasmodics Among Finnish Community-Dwelling Persons With Alzheimer Disease
Torvinen-Kiiskinen S; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S
Article: BMC RESEARCH NOTES. 2014;7:796
From prescriptions to drug use periods - things to notice.
Tanskanen A; Taipale H; Koponen M; Tolppanen A-M; Hartikainen S; Ahonen R; Tiihonen J
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2014;24(11):1729-1737
High prevalence of psychotropic drug use among persons with and without Alzheimer's disease in Finnish nationwide cohort
Taipale H; Koponen M; Tanskanen A; Tolppanen A-M; Tiihonen J; Hartikainen S
Article: JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. 2014;34(4):435-440
Antipsychotic Doses Among Community-Dwelling Persons With Alzheimer Disease in Finland
Taipale H; Koponen M; Tanskanen A; Tolppanen A-M; Tiihonen J; Hartikainen S
Article: JOURNAL OF ALZHEIMERS DISEASE. 2014;41(4):1223-1228
Antipsychotic Polypharmacy among a Nationwide Sample of Community-Dwelling Persons with Alzheimer's Disease
Taipale H; Koponen M; Tanskanen A; Tolppanen A-M; Tiihonen J; Hartikainen S
Article: INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY. 2014;29(4):216-223
Antidementia drug use among community-dwelling individuals with Alzheimer's disease in Finland: a nationwide register-based study
Taipale H; Tanskanen A; Koponen M; Tolppanen A-M; Tiihonen J; Hartikainen S
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2014;111(9):3520-3525
Distance to health services affects local-level vaccine efficacy for pneumococcal conjugate vaccine (PCV) among rural Filipino children
Root ED; Lucero M; Nohynek H; Anthamatten P; Thomas DSK; Tallo V; Tanskanen A; Quiambao BP; Puumalainen T; Lupisan SP; Ruutu P; Ladesma E; Williams GM; Riley I; Simoes EAF
Article: VACCINE. 2013;32(1):159-164
Design questions for Streptococcus pneumoniae vaccine trials with a colonisation endpoint.
Auranen K; Rinta-Kokko H; Goldblatt D; Nohynek H; O'Brien KL; Satzke C; Simell B; Tanskanen A; Käyhty H
Article: SCHIZOPHRENIA BULLETIN. 2013;39(5):1067-1076
Genetic Risk for Schizophrenia, Obstetric Complications, and Adolescent School Outcome: Evidence for Gene-Environment Interaction
Forsyth JK; Ellman LM; Tanskanen A; Mustonen U; Huttunen MO; Suvisaari J; Cannon TD
Article: CLINICAL EPIDEMIOLOGY. 2013;5:277-285
Use of existing data sources in clinical epidemiology: Finnish health care registers in Alzheimer's disease research - the Medication use among persons with Alzheimer's disease (MEDALZ-2005) study.
Tolppanen A-M; Taipale H; Koponen M; Lavikainen P; Tanskanen A; Tiihonen J; Hartikainen S
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2013;48(1):42-50
Medication use among inflammatory bowel disease patients: excessive consumption of antidepressants and analgesics
Haapamaki J; Tanskanen A; Roine RP; Blom M; Turunen U; Mantyla J; Farkkila MA; Arkkila PET
Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2012;21(11):1227-1231
Outcome of patients after market withdrawal of thioridazine: A retrospective analysis in a nationwide cohort
Purhonen M; Koponen H; Tiihonen J; Tanskanen A
Article: BIOLOGICAL PSYCHIATRY. 2012;71(9):836-839
Evidence for Shared Susceptibility to Epilepsy and Psychosis: A Population-Based Family Study
Clarke MC; Tanskanen A; Huttunen MO; Clancy M; Cotter DR; Cannon M
Article: BMC RESEARCH NOTES. 2012;5:51
Geographic Information System and tools of spatial analysis in a pneumococcal vaccine trial.
Tanskanen A; Nillos LT; Lehtinen A; Nohynek H; Sanvictores DHM; Simões EA; Tallo VL; Lucero MG; ARIVAC Consortium
Article: SCHIZOPHRENIA RESEARCH. 2011;133(1-3):125-132
Advanced paternal age and parental history of schizophrenia.
Miller B; Suvisaari J; Miettunen J; Järvelin M-R; Haukka J; Tanskanen A; Lönnqvist J; Isohanni M; Kirkpatrick B
Article: AMERICAN JOURNAL OF PSYCHIATRY. 2011;168(12):1295-1302
Increased risk of schizophrenia from additive interaction between infant motor developmental delay and obstetric complications: evidence from a population-based longitudinal study.
Clarke MC; Tanskanen A; Huttunen M; Leon DA; Murray RM; Jones PB; Cannon M
Article: SCHIZOPHRENIA RESEARCH. 2010;121(1-3):218-226
Paternal age and mortality in nonaffective psychosis.
Miller B; Pihlajamaa J; Haukka J; Cannon M; Henriksson M; Heilä H; Huttunen M; Tanskanen A; Lönnqvist J; Suvisaari J; Kirkpatrick B
Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2010;171(2):169-176
Between-strain competition in acquisition and clearance of pneumococcal carriage--epidemiologic evidence from a longitudinal study of day-care children.
Auranen K; Mehtälä J; Tanskanen A; S Kaltoft M
Article: INTERNATIONAL JOURNAL OF CANCER. 2010;126(1):279-284
Incidence of cancer and statin usage-record linkage study
Haukka J; Sankila R; Klaukka T; Lonnqvist J; Niskanen L; Tanskanen A; Wahlbeck K; Tiihonen J
Article: INTERNATIONAL JOURNAL OF CANCER. 2010;126(1):285-296
Incidence of cancer and antidepressant medication: record linkage study
Haukka J; Sankila R; Klaukka T; Lonnqvist J; Niskanen L; Tanskanen A; Wahlbeck K; Tiihonen J
Article: LANCET. 2009;374(9690):620-627
11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)
Tiihonen J; Lonnqvist J; Wahlbeck K; Klaukka T; Niskanen L; Tanskanen A; Haukka J
Article: BMC INFECTIOUS DISEASES. 2008;8:173
Clustering of serotypes in a longitudinal study of Streptococcus pneumoniae carriage in three day care centres.
Leino T; Hoti F; Syrjänen R; Tanskanen A; Auranen K
Article: ARCHIVES OF GENERAL PSYCHIATRY. 2006;63(12):1358-1367
Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort
Tiihonen J; Lonnqvist J; Wahlbeck K; Klaukka T; Tanskanen A; Haukka J
Article: CONSERVATION BIOLOGY. 2002;16(5):1398-1408
Method for selection of old-forest reserves
Siitonen P; Tanskanen A; Lehtinen A
Article: BRITISH JOURNAL OF PSYCHIATRY. 2002;180:496-501
Perinatal and childhood risk factors for later criminality and violence in schizophrenia. Longitudinal, population-based study.
Cannon M; Huttunen MO; Tanskanen AJ; Arseneault L; Jones PB; Murray RM
Article: PSYCHOLOGICAL MEDICINE. 2000;30(2):315-324
Decreasing seasonal variation of births in schizophrenia.
Suvisaari JM; Haukka JK; Tanskanen AJ; Lönnqvist JK
Article: CONSERVATION BIOLOGY. 1999;13(6):1293-1300
Selection of islands for conservation in the urban archipelago of Helsinki, Finland
Ranta P; Tanskanen A; Niemelä J; Kurtto A
Article: HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL. 1999;14(7):491-497
Motor co-ordination deficits as predictors of schizophrenia among Finnish school children
Cannon M; Jones P; Huttunen MO; Tanskanen A; Murray RM
Article: AMERICAN JOURNAL OF PSYCHIATRY. 1999;156(7):1100-1102
Association between prenatal exposure to poliovirus infection and adult schizophrenia.
Suvisaari J; Haukka J; Tanskanen A; Hovi T; Lönnqvist J
Article: ARCHIVES OF GENERAL PSYCHIATRY. 1999;56(5):457-463
School performance in Finnish children and later development of schizophrenia: a population-based longitudinal study.
Cannon M; Jones P; Huttunen MO; Tanskanen A; Huttunen T; Rabe-Hesketh S; Murray RM
Article: BRITISH JOURNAL OF PSYCHIATRY. 1998;173:494-500
Age at onset and outcome in schizophrenia are related to the degree of familial loading.
Suvisaari JM; Haukka J; Tanskanen A; Lönnqvist JK
Visa fler

Alla övriga publikationer

Letter: WORLD PSYCHIATRY. 2024;23(2):296-298
Medication use and sickness absence from work in bipolar disorder: a nationwide register-based study
Holm M; Tanskanen A; Tiihonen J; Taipale H
Corrigendum: JAMA PSYCHIATRY. 2024;81(1):110
Author Name Change.
Corrigendum: SCHIZOPHRENIA BULLETIN. 2023;49(1):228
Optimal Doses of Specific Antipsychotics for Relapse Prevention in a Nationwide Cohort of Patients with Schizophrenia (vol 48, pg 774, 2022)
Taipale H; Tanskanen A; Luykx JJ; Solmi M; Leucht S; Correll CU; Tiihonen J
Letter: LANCET PSYCHIATRY. 2022;9(7):536-537
Real-world effectiveness studies of low doses of antipsychotics Reply
Taipale H; Tanskanen A; Correll CU; Tiihonen J
Letter: LANCET PSYCHIATRY. 2022;9(7):539-540
Clozapine and the risk of haematological malignancies Reply
Tiihonen J; Tanskanen A; Bell JS; Dawson JL; Kataja V; Taipale H
Corrigendum: JAMA PSYCHIATRY. 2022;79(5):516
Errors in Figures 1 and 2.
Review: NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2022;136:104608
Half a century of research on antipsychotics and schizophrenia: A scientometric study of hotspots, nodes, bursts, and trends
Sabe M; Pillinger T; Kaiser S; Chen C; Taipale H; Tanskanen A; Tiihonen J; Leucht S; Correll CU; Solmi M
Corrigendum: BRITISH JOURNAL OF PSYCHIATRY. 2020;216(5):285
The role of prenatal stress as a pathway to personality disorder: longitudinal birth cohort study - CORRIGENDUM.
Brannigan R; Tanskanen A; Huttunen MO; Cannon M; Leacy FP; Clarke MC
Letter: AMERICAN JOURNAL OF PSYCHIATRY. 2018;175(12):1267
Risk of Treatment Failure: Response to Ghosh and Noble
Tiihonen J; Tanskanen A; Taipale H
Letter: AMERICAN JOURNAL OF PSYCHIATRY. 2018;175(9):909
Risk of Treatment Failure: Response to Czobor and Volavka
Tiihonen J; Tanskanen A; Taipale H
Editorial comment: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2018;47(11):1544-1545
Editorial: let's take a break from studying the PPI-fracture association-Authors' reply
Torvinen-Kiiskinen S; Tolppanen A-M; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
Corrigendum: SCHIZOPHRENIA BULLETIN. 2016;42(2):528
Antipsychotic treatment and mortality in schizophrenia (vol 41, pg 656, 2015)
Torniainen M; Mittendorfer-Rutz E; Tanskanen A; Bjorkenstam C; Suvisaari J; Alexanderson K; Tiihonen J
Letter: WORLD PSYCHIATRY. 2015;14(2):245-247
Psychotropic drugs and homicide: A prospective cohort study from Finland
Tiihonen J; Lehti M; Aaltonen M; Kivivuori J; Kautiainen H; Virta LJ; Hoti F; Tanskanen A; Korhonen P
Review: VACCINE. 2013;32(1):153-158
Colonisation endpoints in Streptococcus pneumoniae vaccine trials.
Auranen K; Rinta-Kokko H; Goldblatt D; Nohynek H; O'Brien KL; Satzke C; Simell B; Tanskanen A; Käyhty H; Pneumococcal Carriage Group (PneumoCarr)
Published conference paper: SCHIZOPHRENIA RESEARCH. 2013;143(2-3):363-366
Sudden death of father or sibling in early childhood increases risk for psychotic disorder
Clarke MC; Tanskanen A; Huttunen MO; Cannon M
Letter: BMC RESEARCH NOTES. 2012;5:274
The data management of a phase III efficacy trial of an 11-valent pneumococcal conjugate vaccine and related satellite studies conducted in the Philippines.
Sanvictores DHM; Lucero MG; Nohynek H; Tallo VL; Tanskanen A; Nillos LT; Williams G; ARIVAC Consortium
Published conference paper: AMERICAN JOURNAL OF PSYCHIATRY. 2009;166(9):1025-1030
Evidence for an interaction between familial liability and prenatal exposure to infection in the causation of schizophrenia.
Clarke MC; Tanskanen A; Huttunen M; Whittaker JC; Cannon M
Published conference paper: ENVIRONMENTAL SCIENCE & POLICY. 2003;6(3):301-309
Selecting forest reserves with a multiobjective spatial algorithm
Siitonen P; Tanskanen A; Lehtinen A
Published conference paper: SCHIZOPHRENIA RESEARCH. 2002;54(1-2):7-16
Adult schizotypal personality characteristics and prenatal influenza in a Finnish birth cohort.
Machón RA; Huttunen MO; Mednick SA; Sinivuo J; Tanskanen A; Bunn Watson J; Henriksson M; Pyhälä R
Published conference paper: ARCHIVES OF GENERAL PSYCHIATRY. 1999;56(8):733-740
Decline in the incidence of schizophrenia in Finnish cohorts born from 1954 to 1965.
Suvisaari JM; Haukka JK; Tanskanen AJ; Lönnqvist JK

Anställningar

Forskningsspecialist, Klinisk neurovetenskap, Karolinska Institutet, 2021-2026
Forskningsspecialist, Klinisk neurovetenskap, Karolinska Institutet, 2025-2025

Artiklar

Alla övriga publikationer

Anställningar

Nyheter från KI

Kalenderhändelser från KI